Proteonomix, Inc.
PROT
Rank in Stocks
#35156
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics... Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The companyโs products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$791.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Proteonomix, Inc. (PROT)
Category
Healthcare
Operating Margin for Proteonomix, Inc. (PROT)
Operating Margin as of November 2026 TTM: -5,026.15%
According to Proteonomix, Inc.'s latest financial reports, its current operating margin (TTM) is -5,026.15%. At the end of 2011 the company had an operating margin of -5,026.15%.
Operating Margin history for Proteonomix, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5,026.15% | 0.00% |
| 2011 | -5,026.15% | 21.39% |
| 2010 | -4,140.61% | 53.58% |
| 2009 | -2,696.14% | -26.69% |
| 2008 | -3,677.73% | 1,069.35% |
| 2002 | -314.51% | 44.09% |
| 2001 | -218.28% | 2.60% |
| 2000 | -212.75% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.97% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Proteonomix, Inc.'s operating margin
What is Proteonomix, Inc.'s operating margin?
Proteonomix, Inc.'s operating margin is -5,026.15%, as of Nov 2026.
What was Proteonomix, Inc.'s operating margin in 2011?
In 2011, Proteonomix, Inc.'s operating margin was -5,026.15%, compared with -4,140.61% in 2010.
How has Proteonomix, Inc.'s operating margin changed since 2008?
From 2008 to 2011, Proteonomix, Inc.'s operating margin was highest in 2009 (-2,696.14%) and lowest in 2011 (-5,026.15%).
How does Proteonomix, Inc.'s operating margin compare with similar companies?
Proteonomix, Inc.'s operating margin (-5,026.15%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.